Biacore is a life science products company, based in Sweden specializing in measuring protein-protein interaction and binding affinity. The technology is based on surface plasmon resonance (SPR), an optical phenomenon that enables detection of unlabeled interactants in real time. The SPR-based biosensors can be used in determination of active concentration, screening and characterization in terms of both affinity and kinetics. Biology studies the variety of life (clockwise from top-left) E. coli, tree fern, gazelle, Goliath beetle Biology is the science of life (from the Greek words bios = life and logos = word). ... Protein-protein interactions refer to the association of protein molecules and the study of these associations from the perspective of biochemistry, signal transduction and networks. ... Look up affinity in Wiktionary, the free dictionary. ... Surface plasmon resonance, or SPR, is a biophysical technique used by biochemists to measure the binding interactions of very small amounts of a target protein. ... Kinetics refers to two different areas of science: Chemical kinetics studies reaction rates. ...
Biacore was founded in 1984 under the name of Pharmacia Biosensor AB after the merger of Linköping Institute of Technology and the Swedish National Defense Research Institute (FOA). In 1996 the company changed its name to Biacore AB Corporation. In June 2006 GE Healthcare acquired Biacore for $390 million. 1984 (MCMLXXXIV) was a leap year starting on Sunday of the Gregorian calendar. ... The Linköping Institute of Technology or Linköpings tekniska högskola is a university school, at Linköping University, located in Linköping , Sweden and Norrköping, Sweden. ... 1996 (MCMXCVI) was a leap year starting on Monday of the Gregorian calendar, and was designated the International Year for the Eradication of Poverty. ... GE Healthcare is a $14 billion (USD) unit of General Electric. ...
BIAcore's competition includes Attana AB, a Stockholm based biotechnology firm, and Hercules, CA based Bio-Rad Laboratories' ProteOn XPR36 Protein Interaction Array System.
BIAcore is a global supplier of systems for protein interaction analysis, an area of increasing importance for scientists in the academic, pharmaceutical, biotechnology and diagnostic markets.
BIAcore was founded in 1984 under the name of Pharmacia Biosensor AB after the merger of Linköping Institute of Technology and the Swedish National Defense Research Institute (FOA).
The result has been Biacore® S51, the most sensitive and highest throughput system yet, designed to target QSAR based lead optimization and early ADME, and Biacore® C, a novel and unique development system designed in conjunction with Boehringer Ingelheim for the quantification of well characterized biochemicals.
Biacore(R) S51 was introduced during the third quarter of 2001 and has been well accepted by customers in both the pharmaceutical and biotechnology industries.
In the second half of 2001, Biacore acquired an exclusive license to the majority of the proprietary fluorescent cell-based assay technology developed by the U.S. company Axiom Biotechnologies Inc. This acquisition was made to enable Biacore to speed up the commercialization of this important technology, which is complementary to the Company's own molecular-based assay systems.
Biacore expects that the combination of these two systems will provide researchers with detailed information on the biological activity of potential drug candidates in a competitive timeframe and to a depth and quality superior to existing analytical instrumentation.